DIFFERENCES IN ATTENTIONAL FUNCTION AMONG ADULT CANCER PATIENTS WHO ARE UNDERGOING CANCER TREATMENT

2.50
Hdl Handle:
http://hdl.handle.net/10755/165281
Category:
Abstract
Type:
Presentation
Title:
DIFFERENCES IN ATTENTIONAL FUNCTION AMONG ADULT CANCER PATIENTS WHO ARE UNDERGOING CANCER TREATMENT
Author(s):
Jansen, Catherine; Miaskowski, Christine; West, Claudia; Dodd, Marylin; Lee, Kathryn
Author Details:
Catherine Jansen, RN,MS, OCN, Kaiser Permanente Medical Center, San Francisco, California, USA; Christine Miaskowski, RN, PhD; Claudia West, RN, MS; Marylin Dodd, RN, PhD; Kathryn Lee, RN, PhD
Abstract:
Impairment in cognitive function is a newly-recognized side effect of cancer treatment. Attention, an important component of cognition, is essential for informed consent, recognition of side effects, and the ability to learn self-care. Although anxiety, depression, and fatigue are common during cancer treatment, and can negatively impact an individual’s ability to pay attention and concentrate, relatively little is known about attention and its relationship to anxiety, depression, and fatigue during cancer treatment. The purpose of this study was to examine attentional function, anxiety, depression, and fatigue in patients undergoing cancer treatment. The U.C.S.F.’s “Symptom Management Model” provided the framework for this study. This study descriptive, correlational study enrolled a convenience sample (n = 194) was drawn from six outpatient oncology clinics. Instruments included the Attentional Function Index (AFI), the Speilberger State and Trait Anxiety Questionnaire (STAI), the Center for Epidemiological Studies Depression Scale (CES-D), and the Lee Fatigue Scale (LFS). The AFI is a 16-item numeric rating scale (ranging from 0-10, with descriptive anchors) which measures directed attention. The STAI is a 20-item, 4-point Likert scale (ranging from 0-4) which measures anxiety. The CESD is a 20-item, 4-point Likert scale (ranging from 0-4) which measures depression. The LFS is an 18-item numeric rating scale (ranging from 0-10, with descriptive anchors) which measures fatigue and energy. Each instrument has established reliability and validity. Descriptive statistics, t-tests, and Pearson Product Moment Correlations were used to analyze the data. The results of this study revealed significantly poorer attentional function in patients who were receiving chemotherapy compared to other cancer treatments (p = 0.011). Regardless of the type of cancer treatment employed, patients with poorer levels of attentional function reported significantly higher anxiety (r = -0.50, p < 0.01), depression (r = - 0.56 p < 0.01), and fatigue (r = -0.53, p < 0.01) scores. Conclusion: Although anxiety, depression, and fatigue negatively impact attention, chemotherapy has a greater negative impact on attention compared to other types of cancer treatment. These results suggest the need for further research on chemotherapy-induced impairments in attention, as well as other components of cognitive function.
Repository Posting Date:
27-Oct-2011
Date of Publication:
27-Oct-2011
Conference Date:
2005
Conference Name:
30th Annual Oncology Nursing Society Congress
Conference Host:
Oncology Nursing Society
Conference Location:
Orlando, Florida, USA
Sponsors:
Funding Sources: National Cancer Institute; American Cancer Society Doctoral Scholarship DSCN 02-209-01.
Note:
This is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.

Full metadata record

DC FieldValue Language
dc.type.categoryAbstracten_US
dc.typePresentationen_GB
dc.titleDIFFERENCES IN ATTENTIONAL FUNCTION AMONG ADULT CANCER PATIENTS WHO ARE UNDERGOING CANCER TREATMENTen_GB
dc.contributor.authorJansen, Catherineen_US
dc.contributor.authorMiaskowski, Christineen_US
dc.contributor.authorWest, Claudiaen_US
dc.contributor.authorDodd, Marylinen_US
dc.contributor.authorLee, Kathrynen_US
dc.author.detailsCatherine Jansen, RN,MS, OCN, Kaiser Permanente Medical Center, San Francisco, California, USA; Christine Miaskowski, RN, PhD; Claudia West, RN, MS; Marylin Dodd, RN, PhD; Kathryn Lee, RN, PhDen_US
dc.identifier.urihttp://hdl.handle.net/10755/165281-
dc.description.abstractImpairment in cognitive function is a newly-recognized side effect of cancer treatment. Attention, an important component of cognition, is essential for informed consent, recognition of side effects, and the ability to learn self-care. Although anxiety, depression, and fatigue are common during cancer treatment, and can negatively impact an individual&rsquo;s ability to pay attention and concentrate, relatively little is known about attention and its relationship to anxiety, depression, and fatigue during cancer treatment. The purpose of this study was to examine attentional function, anxiety, depression, and fatigue in patients undergoing cancer treatment. The U.C.S.F.&rsquo;s &ldquo;Symptom Management Model&rdquo; provided the framework for this study. This study descriptive, correlational study enrolled a convenience sample (n = 194) was drawn from six outpatient oncology clinics. Instruments included the Attentional Function Index (AFI), the Speilberger State and Trait Anxiety Questionnaire (STAI), the Center for Epidemiological Studies Depression Scale (CES-D), and the Lee Fatigue Scale (LFS). The AFI is a 16-item numeric rating scale (ranging from 0-10, with descriptive anchors) which measures directed attention. The STAI is a 20-item, 4-point Likert scale (ranging from 0-4) which measures anxiety. The CESD is a 20-item, 4-point Likert scale (ranging from 0-4) which measures depression. The LFS is an 18-item numeric rating scale (ranging from 0-10, with descriptive anchors) which measures fatigue and energy. Each instrument has established reliability and validity. Descriptive statistics, t-tests, and Pearson Product Moment Correlations were used to analyze the data. The results of this study revealed significantly poorer attentional function in patients who were receiving chemotherapy compared to other cancer treatments (p = 0.011). Regardless of the type of cancer treatment employed, patients with poorer levels of attentional function reported significantly higher anxiety (r = -0.50, p &lt; 0.01), depression (r = - 0.56 p &lt; 0.01), and fatigue (r = -0.53, p &lt; 0.01) scores. Conclusion: Although anxiety, depression, and fatigue negatively impact attention, chemotherapy has a greater negative impact on attention compared to other types of cancer treatment. These results suggest the need for further research on chemotherapy-induced impairments in attention, as well as other components of cognitive function.en_GB
dc.date.available2011-10-27T12:15:44Z-
dc.date.issued2011-10-27en_GB
dc.date.accessioned2011-10-27T12:15:44Z-
dc.conference.date2005en_US
dc.conference.name30th Annual Oncology Nursing Society Congressen_US
dc.conference.hostOncology Nursing Societyen_US
dc.conference.locationOrlando, Florida, USAen_US
dc.description.sponsorshipFunding Sources: National Cancer Institute; American Cancer Society Doctoral Scholarship DSCN 02-209-01.-
dc.description.noteThis is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.-
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.